S&P 500   4,561.87 (+0.15%)
DOW   35,523.19 (+0.30%)
QQQ   391.01 (+0.21%)
AAPL   189.43 (-0.51%)
MSFT   379.48 (-0.84%)
META   333.25 (-1.69%)
GOOGL   135.48 (-1.25%)
AMZN   146.99 (-0.03%)
TSLA   247.42 (+0.28%)
NVDA   482.15 (+0.82%)
NIO   7.22 (+0.14%)
BABA   74.97 (-2.31%)
AMD   124.51 (+2.05%)
T   16.31 (+0.80%)
F   10.66 (+2.80%)
MU   76.75 (+0.83%)
CGC   0.57 (+4.96%)
GE   119.06 (+0.18%)
DIS   92.99 (+0.53%)
AMC   7.26 (+8.36%)
PFE   30.08 (+1.31%)
PYPL   58.37 (-0.17%)
XOM   103.57 (-0.32%)
S&P 500   4,561.87 (+0.15%)
DOW   35,523.19 (+0.30%)
QQQ   391.01 (+0.21%)
AAPL   189.43 (-0.51%)
MSFT   379.48 (-0.84%)
META   333.25 (-1.69%)
GOOGL   135.48 (-1.25%)
AMZN   146.99 (-0.03%)
TSLA   247.42 (+0.28%)
NVDA   482.15 (+0.82%)
NIO   7.22 (+0.14%)
BABA   74.97 (-2.31%)
AMD   124.51 (+2.05%)
T   16.31 (+0.80%)
F   10.66 (+2.80%)
MU   76.75 (+0.83%)
CGC   0.57 (+4.96%)
GE   119.06 (+0.18%)
DIS   92.99 (+0.53%)
AMC   7.26 (+8.36%)
PFE   30.08 (+1.31%)
PYPL   58.37 (-0.17%)
XOM   103.57 (-0.32%)
S&P 500   4,561.87 (+0.15%)
DOW   35,523.19 (+0.30%)
QQQ   391.01 (+0.21%)
AAPL   189.43 (-0.51%)
MSFT   379.48 (-0.84%)
META   333.25 (-1.69%)
GOOGL   135.48 (-1.25%)
AMZN   146.99 (-0.03%)
TSLA   247.42 (+0.28%)
NVDA   482.15 (+0.82%)
NIO   7.22 (+0.14%)
BABA   74.97 (-2.31%)
AMD   124.51 (+2.05%)
T   16.31 (+0.80%)
F   10.66 (+2.80%)
MU   76.75 (+0.83%)
CGC   0.57 (+4.96%)
GE   119.06 (+0.18%)
DIS   92.99 (+0.53%)
AMC   7.26 (+8.36%)
PFE   30.08 (+1.31%)
PYPL   58.37 (-0.17%)
XOM   103.57 (-0.32%)
S&P 500   4,561.87 (+0.15%)
DOW   35,523.19 (+0.30%)
QQQ   391.01 (+0.21%)
AAPL   189.43 (-0.51%)
MSFT   379.48 (-0.84%)
META   333.25 (-1.69%)
GOOGL   135.48 (-1.25%)
AMZN   146.99 (-0.03%)
TSLA   247.42 (+0.28%)
NVDA   482.15 (+0.82%)
NIO   7.22 (+0.14%)
BABA   74.97 (-2.31%)
AMD   124.51 (+2.05%)
T   16.31 (+0.80%)
F   10.66 (+2.80%)
MU   76.75 (+0.83%)
CGC   0.57 (+4.96%)
GE   119.06 (+0.18%)
DIS   92.99 (+0.53%)
AMC   7.26 (+8.36%)
PFE   30.08 (+1.31%)
PYPL   58.37 (-0.17%)
XOM   103.57 (-0.32%)

Sabra Health Care REIT Stock Price, News & Analysis (NASDAQ:SBRA)

$14.49
-0.03 (-0.21%)
(As of 02:27 PM ET)
Compare
Today's Range
$14.43
$14.63
50-Day Range
$13.36
$14.60
52-Week Range
$10.08
$14.82
Volume
826,787 shs
Average Volume
2.23 million shs
Market Capitalization
$3.35 billion
P/E Ratio
N/A
Dividend Yield
8.28%
Price Target
$14.59

Sabra Health Care REIT MarketRank™ Stock Analysis

Analyst Rating
Hold
2.45 Rating Score
Upside/​Downside
0.7% Upside
$14.59 Price Target
Short Interest
Healthy
4.90% of Shares Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
N/A
Insider Trading
Acquiring Shares
$24,591 Bought Last Quarter
Proj. Earnings Growth
6.11%
From $1.31 to $1.39 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.20 out of 5 stars

Finance Sector

506th out of 853 stocks

Real Estate Investment Trusts Industry

95th out of 179 stocks


SBRA stock logo

About Sabra Health Care REIT Stock (NASDAQ:SBRA)

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing - Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing - Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures. As of September 30, 2023, Sabra's real estate properties held for investment included 37,606 beds/units, spread across the United States and Canada.

SBRA Stock Price History

SBRA Stock News Headlines

The Only Practical Solution to the World’s Looming Energy Crisis
There’s just one problem: There are more plans for new uses of nuclear than there is uranium to fuel the plants!
Q3 2023 Sabra Health Care REIT Inc Earnings Call
Sabra Reports Third Quarter 2023 Results
The Only Practical Solution to the World’s Looming Energy Crisis
There’s just one problem: There are more plans for new uses of nuclear than there is uranium to fuel the plants!
Analyst Ratings for Sabra Health Care REIT
Where Sabra Health Care REIT Stands With Analysts
Sabra Health Care: A 9% Yielding Healthcare REIT
See More Headlines
Receive SBRA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sabra Health Care REIT and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/04/2022
Ex-Dividend for 8/31 Dividend
8/16/2023
Dividend Payable
8/31/2023
Ex-Dividend for 11/30 Dividend
11/16/2023
Today
11/29/2023
Dividend Payable
11/30/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
2/20/2024

Industry, Sector and Symbol

Industry
Real estate investment trusts
Sub-Industry
Specialized REITs
Sector
Finance
Current Symbol
NASDAQ:SBRA
CUSIP
78573L10
Employees
42
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$14.59
High Stock Price Target
$16.00
Low Stock Price Target
$12.50
Potential Upside/Downside
+0.5%
Consensus Rating
Hold
Rating Score (0-4)
2.45
Research Coverage
11 Analysts

Profitability

Net Income
$-77,610,000.00
Pretax Margin
0.58%

Debt

Sales & Book Value

Annual Sales
$624.81 million
Cash Flow
$0.48 per share
Book Value
$12.41 per share

Miscellaneous

Free Float
228,908,000
Market Cap
$3.36 billion
Optionable
Optionable
Beta
1.24

Social Links

7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Key Executives















SBRA Stock Analysis - Frequently Asked Questions

Should I buy or sell Sabra Health Care REIT stock right now?

11 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Sabra Health Care REIT in the last twelve months. There are currently 6 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" SBRA shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SBRA, but not buy additional shares or sell existing shares.
View SBRA analyst ratings
or view top-rated stocks.

What is Sabra Health Care REIT's stock price target for 2024?

11 Wall Street analysts have issued 1-year price objectives for Sabra Health Care REIT's stock. Their SBRA share price targets range from $12.50 to $16.00. On average, they anticipate the company's share price to reach $14.59 in the next twelve months. This suggests a possible upside of 0.9% from the stock's current price.
View analysts price targets for SBRA
or view top-rated stocks among Wall Street analysts.

How have SBRA shares performed in 2023?

Sabra Health Care REIT's stock was trading at $12.43 on January 1st, 2023. Since then, SBRA shares have increased by 16.3% and is now trading at $14.46.
View the best growth stocks for 2023 here
.

When is Sabra Health Care REIT's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 20th 2024.
View our SBRA earnings forecast
.

How were Sabra Health Care REIT's earnings last quarter?

Sabra Health Care REIT, Inc. (NASDAQ:SBRA) released its quarterly earnings data on Wednesday, May, 4th. The real estate investment trust reported $0.18 EPS for the quarter, beating analysts' consensus estimates of $0.17 by $0.01. Sabra Health Care REIT had a negative net margin of 13.61% and a negative trailing twelve-month return on equity of 2.98%. During the same quarter last year, the company earned $0.39 EPS.

How often does Sabra Health Care REIT pay dividends? What is the dividend yield for Sabra Health Care REIT?

Sabra Health Care REIT declared a quarterly dividend on Monday, November 6th. Stockholders of record on Friday, November 17th will be paid a dividend of $0.30 per share on Thursday, November 30th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 8.30%. The ex-dividend date is Thursday, November 16th.
Read our dividend analysis for SBRA
.

Is Sabra Health Care REIT a good dividend stock?

Sabra Health Care REIT (NASDAQ:SBRA) pays an annual dividend of $1.20 per share and currently has a dividend yield of 8.28%. SBRA has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.
Read our dividend analysis for SBRA.

What other stocks do shareholders of Sabra Health Care REIT own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Sabra Health Care REIT investors own include AT&T (T), Omega Healthcare Investors (OHI), Realty Income (O), Medical Properties Trust (MPW), Energy Transfer (ET), Verizon Communications (VZ), Bank of America (BAC), Annaly Capital Management (NLY), Ventas (VTR) and New Residential Investment (NRZ).

Who are Sabra Health Care REIT's major shareholders?

Sabra Health Care REIT's stock is owned by a variety of institutional and retail investors. Top institutional investors include Principal Financial Group Inc. (9.08%), JPMorgan Chase & Co. (5.84%), Bank of New York Mellon Corp (2.13%), LSV Asset Management (1.85%), Charles Schwab Investment Management Inc. (1.77%) and Northern Trust Corp (1.45%). Insiders that own company stock include Catherine Cusack, Harold W Jr Andrews, Michael J Foster and Michael Lourenco Costa.
View institutional ownership trends
.

How do I buy shares of Sabra Health Care REIT?

Shares of SBRA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:SBRA) was last updated on 11/29/2023 by MarketBeat.com Staff

My Account -